跳至主要内容
临床试验/JPRN-UMIN000012120
JPRN-UMIN000012120招募中未知

The effects of teneligliptin on cardiac function and endothelial function in patients with type 2 diabetes - Efficacy of teneligliptin in patients with type 2 diabetes

Dokkyo Medical University0 个研究点目标入组 40 人开始时间: 2013年10月28日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Type-1 diabetes, diabetes due to a pancreatic disorder, or secondary diabetes due to conditions such as Cushing's syndrome and acromegaly 2)Application of contraindications contained in the package insert 3)Heart failure (NYHA grade 3-4) 4)Patients prone to QT prolongation 5)Excessive alcohol consumption 6)Pregnant women, women suspected of being pregnant, or lactating women 7)History of myocardial infarction 8)The medication in the treatment of diabetes drugs not be used with insurance 9)Under administration of GLP-1 agonists

研究者

相似试验